Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$25.29 -1.14 (-4.31%)
At close: Oct 1, 2026 · 4:00 PM EDT

Arcutis Biotherapeutics (ARQT) Accumulated Expenses (2019 - 2026)

Updated

Arcutis Biotherapeutics' Accumulated Expenses was $146.79 million in Q2 2026, up 67.1% from $87.85 million a year earlier and up 7.2% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Arcutis Biotherapeutics came in at $116.31 million, up 74.1% from FY2024.

  • Accumulated Expenses has now increased for six consecutive years, with a five-year compound annual growth rate of 49.7% (FY2020 to FY2025).
  • In earlier years, Accumulated Expenses was $66.79 million in FY2024 (+96.8%), $33.94 million in FY2023 (+19.8%), $28.32 million in FY2022 (+10.9%) and $25.54 million in FY2021 (+65.2%).
  • The Q2 2026 figure marks the highest quarterly Accumulated Expenses in data going back to Q4 2019.
  • Compared with a year earlier, Accumulated Expenses has increased for 19 straight quarters, with growth averaging 89.1% over the last eight quarters.
  • The best year-over-year quarter for Accumulated Expenses over five years was Q2 2024 (growth of 126.7%); the worst was Q3 2021 (a decline of 13.7%).
  • Per Business Quant data, ARQT's Accumulated Expenses in the three quarters before Q2 2026 was $136.96 million (Q1 2026), $116.31 million (Q4 2025) and $92.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Arcutis Biotherapeutics 3.32 Bn 2.60 Bn 118.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 146.79 Mn
Mar 31, 2026 136.96 Mn
Dec 31, 2025 116.31 Mn
Sep 30, 2025 92.98 Mn
Jun 30, 2025 87.85 Mn
Mar 31, 2025 65.76 Mn
Dec 31, 2024 66.79 Mn
Sep 30, 2024 52.79 Mn
Jun 30, 2024 42.63 Mn
Mar 31, 2024 33.58 Mn
Dec 31, 2023 33.94 Mn
Sep 30, 2023 28.00 Mn
Jun 30, 2023 18.81 Mn
Mar 31, 2023 23.86 Mn
Dec 31, 2022 28.32 Mn
Sep 30, 2022 27.80 Mn
Jun 30, 2022 18.46 Mn
Mar 31, 2022 19.99 Mn
Dec 31, 2021 25.54 Mn
Sep 30, 2021 13.88 Mn
API Access

Arcutis Biotherapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARQT&period=max&api_key=YOUR_API_KEY